Cathay Innovation said Tuesday it has closed its Fund III at $1 billion and will continue to back AI startups in digital ...

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following statement regarding its dispute with Renovaro, Inc.

In a landmark announcement that bridges Asia and Europe, Leo International Group has acquired a controlling stake in SPOABG ...

The global Chromatography Accessories & Consumables Market, valued at US$4.79 billion in 2023, is forecasted to grow at a ...

AI researchers, clinicians and entrepreneurs explored the potential of AI for healthcare at a showcase Imperial Global USA event in San Francisco.An ...

SCOTTSDALE, Ariz., May 27, 2025 /PRNewswire/ -- Life365, a leading data engagement and virtual care company, today announced the appointment of healthcare executive and investor Jay Roberts as chief ...

Recursion Pharmaceuticals and Schrodinger leverage their respective AI drug discovery platforms to potentially develop distinguished therapeutic candidates.

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following statement regarding ...

Cathay Innovation today announced the final close of its latest venture capital fund at $1B, making it the ...

Learn about Capex trends, data center growth, and how to invest in the infrastructure powering generative AI. Discover how hyperscaler capex is driving the future of cloud computing and AI.

Praveen Kumar Myakala, a Texas-based software engineer and AI technologist, has emerged as a respected voice in the global artificial intelligence research and innovation ecosystem. With a Master’s ...

See All AI (the "Company"), a pioneering company leveraging artificial intelligence, deep learning, and machine vision for intraoperative 3D surgical imaging and navigation, announced today that it ...